2023
Novel Approaches and Future Directions in Myelodysplastic Syndrome Treatment
Bewersdorf J, Xie Z, Zeidan A. Novel Approaches and Future Directions in Myelodysplastic Syndrome Treatment. The Cancer Journal 2023, 29: 195-202. PMID: 37195776, DOI: 10.1097/ppo.0000000000000658.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsHigh-risk MDS patientsInternational Prognostic Scoring SystemPhase III clinical trialsErythropoiesis-stimulating agentsPrognostic scoring systemRisk stratification toolAdvanced clinical testingStandard of careAcute myeloid leukemiaTelomerase inhibitor imetelstatEncouraging early resultsMyelodysplastic Syndromes TreatmentAnemic patientsAgent monotherapyMDS patientsStratification toolSyndrome treatmentCombination therapyDysplastic changesClinical trialsMyeloid leukemiaTreatment decisionsClonal disorderTreatment selectionClinical testing
2022
Delivery timing for the opioid–exposed infant
Sanusi A, Gray M, Xue Y, Mohr S, Curtis P, Dismukes J, Gentle S, Szychowski J, Brocato B, Casey B, Harper L, Sinkey R. Delivery timing for the opioid–exposed infant. American Journal Of Obstetrics & Gynecology MFM 2022, 4: 100719. PMID: 35977700, PMCID: PMC10961100, DOI: 10.1016/j.ajogmf.2022.100719.Peer-Reviewed Original ResearchConceptsNeonatal opioid withdrawal syndromeOpioid withdrawal syndromeOpioid-exposed infantsIncidence of neonatal opioid withdrawal syndromeNeonatal opioid withdrawal syndrome treatmentLate-term periodsEarly term deliveryOpioid-exposed neonatesWithdrawal syndromePrimary composite outcomeOpioid use disorderNeonatal outcomesTerm deliveryMedication-Assisted TreatmentSyndrome treatmentComposite outcomeRisk of neonatal opioid withdrawal syndromeSeverity of neonatal opioid withdrawal syndromeNeonatal intensive care unit admissionAmerican College of Obstetricians and GynecologistsPositive urine toxicology screenPrimary outcomeSecondary outcomesNeonatal intensive care unitPositive urine drug screen
2021
Anticholinergic prescribing pattern changes of urogynecology providers in response to evidence of potential dementia risk
Menhaji K, Cardenas-Trowers OO, Chang OH, Hall EF, Ringel NE, Falk KN. Anticholinergic prescribing pattern changes of urogynecology providers in response to evidence of potential dementia risk. International Urogynecology Journal 2021, 32: 2819-2826. PMID: 33683426, DOI: 10.1007/s00192-021-04736-8.Peer-Reviewed Original ResearchConceptsAnticholinergic medicationsOveractive bladder syndrome treatmentMajority of respondentsDevelopment of dementiaRisk of dementiaPrior authorization processPrimary outcomePrescribing practicesResultsA totalSyndrome treatmentDementia riskPractice patternsInsurance barriersInsurance restrictionsMedicationsTreatment planWeb-based surveyImpact of insuranceDementiaRecent literatureAnticholinergicsAgonistsRiskDescriptive statisticsTreatment
2012
Respiratory Failure Caused by a Suspicious White Powder
Siew LT, Auerbach M, Baum CR, Pavlovic L, Leventhal JM. Respiratory Failure Caused by a Suspicious White Powder. Pediatric Emergency Care 2012, 28: 918-920. PMID: 22940893, DOI: 10.1097/pec.0b013e318267ec36.Peer-Reviewed Original ResearchConceptsMethadone ingestionRespiratory failureNarcotic dependencyNeonatal abstinence syndrome treatmentNeonatal abstinence syndromeTreatment of toxicityFamily-centered educationMethadone administrationAbstinence syndromeSyndrome treatmentMale infantPediatric providersUnintentional ingestionMore prevalenceAnticipatory guidanceInfantsIngestionMethadoneSymptomsTreatmentSuspicious white powdersMothersFailureSyndromePrevalence
2005
Asperger Syndrome
Klin A, McPartland J, Volkmar F. Asperger Syndrome. 2005, 88-125. DOI: 10.1002/9780470939345.ch4.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply